ADAR1 Capital Management, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1940272
AUSTIN, TX
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$117,782,586
+$13,002,444 QoQ
Shares Held
960,863
-3.3% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
5.70%
of 13F equity value
Holder Rank
#18
of 341 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Dec 31, 2024CallValue
$5,095,200
CallShares
132,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,452,202 across 192 Biotechnology names. PTGX ranks #2 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
This page
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in PTGX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,782,586 | 960,863 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $104,780,142 | 994,119 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $91,634,333 | 1,049,168 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $65,711,360 | 989,182 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,399,773 | 948,069 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $45,442,392 | 939,669 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $39,384,853 | 1,020,333 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $5,095,200 | 132,000 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $44,158,275 | 981,295 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,576,243 | 1,603,932 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $22,728,999 | 785,655 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,605,696 | 200,859 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||